June 28, 2020-- Today, the U.S. Food and Drug Administration approved Crysvita (burosumab-twza) injection to treat patients age two and older with tumor-induced osteomalacia (TIO), a rare disease that is characterized by……
June 02, 2020 - AstraZeneca’s BRILINTA? (ticagrelor) has been approved in the US to reduce the risk of a first heart attack or stroke in high-risk patients with coronary artery disease (CAD), the most common type of hear……
May 26, 2020-- The U.S. Food and Drug Administration today granted approval to VESIcare LS (solifenacin succinate) oral suspension, a liquid taken by mouth, for the treatment of neurogenic detrusor overactivity (NDO), a ……
May 08, 2020 - Today, the U.S. Food and Drug Administration approved Retevmo (selpercatinib) capsules to treat three types of tumors ? non-small cell lung cancer, medullary thyroid cancer and other types of thyroid cance……
Apr. 27, 2020-- Incyte (Nasdaq: INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Pemazyre? (pemigatinib), a kinase inhibitor indicated for the treatment of adults with previously treate……
4 April 2020 - Novo Nordisk today announced that the European Commission (EC) has granted marketing authorisation for Rybelsus? (oral semaglutide), for the treatment of adults with insufficiently controlled type 2 diabet……
Copyright Nanjing Dorra Pharmaceutical Technology Co.,Ltd. @ 2018 China All Rights Reserved 苏ICP备12056923号-1
Tel: 025-82232955 025-82232966
Fax:025-82232933 025-82232944
E-mail: info@dorrapharma.com
